Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

A Global, Phase 1/2, Open-label, Dose Escalation Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Medical Genetics

Awarded By

Moderna Therapeutics, Inc.

Start Date

February 12, 2021

End Date

April 30, 2024
 

Administered By

Pediatrics, Medical Genetics

Awarded By

Moderna Therapeutics, Inc.

Start Date

February 12, 2021

End Date

April 30, 2024